M Tischkowitz

Germline <i>DICER1</i> mutations and familial cystic nephroma

Amin Bahubeshi, Thomas Rio Frio, Nancy Hamel et al. · Journal of Medical Genetics · 2010 · 124 citations

Medicine, Genetics, Pathology +17

Can we define tumors that will respond to PARP inhibitors? A phase II correlative study of olaparib in advanced serous ovarian cancer and triple-negative breast cancer.

Karen A. Gelmon, Hal W. Hirte, A. Robidoux et al. · Journal of Clinical Oncology · 2010 · 103 citations

Medicine, Oncology, Pharmacology +17

Randomized Trial of a Specialist Genetic Assessment Service for Familial Breast Cancer

Kate Brain, J. Gray, Paul Norman et al. · JNCI Journal of the National Cancer Institute · 2000 · 90 citations · Full text

Medicine, Genetics, Oncology +15

Characterization of two Ashkenazi Jewish founder mutations in MSH6 gene causing Lynch syndrome

Leon Raskin, Frank Schwenter, Marina Freytsis et al. · Clinical Genetics · 2010 · 33 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17